LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PD0325901 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2390 | 4093 | 0.5839 | 0.4094 |
MCF7 | PD0325901 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2523 | 4093 | 0.6164 | 0.4555 |
MCF7 | PD173074 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3920 | 4093 | 0.9579 | 0.9402 |
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2969 | 4093 | 0.7256 | 0.6104 |
MCF7 | Pelitinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3818 | 4093 | 0.9329 | 0.9047 |
MCF7 | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1470 | 4093 | 0.3592 | 0.0904 |
MCF7 | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1945 | 4093 | 0.4753 | 0.2552 |
MCF7 | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2452 | 4093 | 0.5992 | 0.4311 |
MCF7 | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4159 | 4093 | 1.0162 | 1.0230 |
MCF7 | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1226 | 4093 | 0.2997 | 0.0059 |
MCF7 | PI103 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1171 | 4093 | 0.2863 | -0.0131 |
MCF7 | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4295 | 4093 | 1.0494 | 1.0701 |
MCF7 | QL-X-138 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1937 | 4093 | 0.4733 | 0.2523 |
MCF7 | QL-XII-47 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1317 | 4093 | 0.3219 | 0.0374 |
MCF7 | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1564 | 4093 | 0.3822 | 0.1230 |
MCF7 | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1432 | 4093 | 0.3500 | 0.0774 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3931 | 4093 | 0.9606 | 0.9441 |
MCF7 | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4219 | 4093 | 1.0309 | 1.0439 |
MCF7 | XL147 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4269 | 4093 | 1.0431 | 1.0612 |
MCF7 | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2897 | 4093 | 0.7079 | 0.5853 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2499 | 4093 | 0.6106 | 0.4473 |
MCF7 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2249 | 4093 | 0.5496 | 0.3607 |
MCF7 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3825 | 4093 | 0.9347 | 0.9073 |
MCF7 | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3974 | 4093 | 0.9710 | 0.9589 |
MCF7 | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3198 | 4093 | 0.7814 | 0.6897 |